Resultados de procura - Isabelle, Ray-Coquard

Limitar resultados
  1. 1
    Soft Tissue and Uterine Leiomyosarcoma

    Soft Tissue and Uterine Leiomyosarcoma por Suzanne George, César Serrano, Martee L. Hensley, Isabelle Ray‐Coquard

    Publicado 2017
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  2. 2
    Challenges for immunotherapy for the treatment of platinum resistant ovarian cancer

    Challenges for immunotherapy for the treatment of platinum resistant ovarian cancer por Olivia Le Saux, Isabelle Ray‐Coquard, Sana Intidhar Labidi‐Galy

    Publicado 2020
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  3. 3
    Lymphopenia in Cancer Patients and its Effects on Response to Immunotherapy: an opportunity for combination with Cytokines?

    Lymphopenia in Cancer Patients and its Effects on Response to Immunotherapy: an opportunity for combination with Cytokines? por Christine Ménétrier‐Caux, Isabelle Ray‐Coquard, Jean‐Yves Blay, Christophe Caux

    Publicado 2019
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  4. 4
    Emerging treatment strategies in recurrent platinum-sensitive ovarian cancer: Focus on trabectedin

    Emerging treatment strategies in recurrent platinum-sensitive ovarian cancer: Focus on trabectedin por Andrés Poveda, Isabelle Ray‐Coquard, Ignacio Romero, José Antonio López‐Guerrero, Nicoletta Colombo

    Publicado 2013
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  5. 5
    Complete response to imatinib in relapsing pigmented villonodular synovitis/tenosynovial giant cell tumor (PVNS/TGCT)

    Complete response to imatinib in relapsing pigmented villonodular synovitis/tenosynovial giant cell tumor (PVNS/TGCT) por Jean‐Yves Blay, Hiba El Sayadi, P. Thiesse, Jérôme Garret, Isabelle Ray‐Coquard

    Publicado 2008
    Ligazón do recurso Ligazón do recurso
    Carta
    Engadir a favoritos
    Gardado en:
  6. 6
    Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials

    Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials por Andreas du Bois, Alexander Reuß, Eric Pujade‐Lauraine, Philipp Harter, Isabelle Ray‐Coquard, Jacobus Pfisterer

    Publicado 2009
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  7. 7
    Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients

    Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients por Thomas Bachelot, Isabelle Ray‐Coquard, Christine Ménétrier‐Caux, M Rastkha, Adeline Duc, Jean‐Yves Blay

    Publicado 2003
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  8. 8
    Potential Role of Lymphadenectomy in Advanced Ovarian Cancer: A Combined Exploratory Analysis of Three Prospectively Randomized Phase III Multicenter Trials

    Potential Role of Lymphadenectomy in Advanced Ovarian Cancer: A Combined Exploratory Analysis of Three Prospectively Randomized Phase III Multicenter Trials por Andreas du Bois, Alexander Reuß, Philipp Harter, Éric Pujade-Lauraine, Isabelle Ray‐Coquard, Jacobus Pfisterer

    Publicado 2010
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  9. 9
    Novel Therapeutic Options for Solitary Fibrous Tumor: Antiangiogenic Therapy and Beyond

    Novel Therapeutic Options for Solitary Fibrous Tumor: Antiangiogenic Therapy and Beyond por Axel de Bernardi, Armelle Dufresne, Florence Mishellany, Jean‐Yves Blay, Isabelle Ray‐Coquard, Mehdi Brahmi

    Publicado 2022
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  10. 10
    Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up por Isabelle Ray‐Coquard, Philippe Morice, Domenica Lorusso, Jaime Prat, Ana Oaknin, Patricia Pautier, Nicoletta Colombo

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  11. 11
    Adjuvant therapy with imatinib in gastrointestinal stromal tumors (GISTs)—review and perspectives

    Adjuvant therapy with imatinib in gastrointestinal stromal tumors (GISTs)—review and perspectives por Marie Laurent, Mehdi Brahmi, Armelle Dufresne, Pierre Méeus, Marie Karanian, Isabelle Ray‐Coquard, Jean‐Yves Blay

    Publicado 2019
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  12. 12
    Recurrent or primary metastatic cervical cancer: current and future treatments

    Recurrent or primary metastatic cervical cancer: current and future treatments por Christine Gennigens, Guy Jérusalem, L. Lapaille, Marjolein De Cuypere, Sylvie Streel, Frédéric Kridelka, Isabelle Ray‐Coquard

    Publicado 2022
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  13. 13
    BRCA1/2 alterations and reversion mutations in the area of PARP inhibitors in high grade ovarian cancer: state of the art and forthcoming challenges

    BRCA1/2 alterations and reversion mutations in the area of PARP inhibitors in high grade ovarian cancer: state of the art and forthcoming challenges por L. Collet, Brunhilde Hanvic, Margherita Turinetto, Isabelle Treilleux, Nicolás Chopin, Olivia Le Saux, Isabelle Ray‐Coquard

    Publicado 2024
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  14. 14
    Outcome of patients with advanced solitary fibrous tumors: the Centre Léon Bérard experience

    Outcome of patients with advanced solitary fibrous tumors: the Centre Léon Bérard experience por Alice Levard, Olfa Derbel, Pierre Méeus, Dominique Ranchère, Isabelle Ray‐Coquard, Jean‐Yves Blay, Philippe A. Cassier

    Publicado 2013
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  15. 15
    First-line PARP inhibitors in ovarian cancer: summary of an ESMO Open - Cancer Horizons round-table discussion

    First-line PARP inhibitors in ovarian cancer: summary of an ESMO Open - Cancer Horizons round-table discussion por Susana Banerjee, Antonio González‐Martín, Philipp Harter, Domenica Lorusso, Kathleen N. Moore, Ana Oaknin, Isabelle Ray‐Coquard

    Publicado 2020
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  16. 16
    PARP-inhibitors in epithelial ovarian cancer: Actual positioning and future expectations

    PARP-inhibitors in epithelial ovarian cancer: Actual positioning and future expectations por Hélène Vanacker, Philipp Harter, Sana Intidhar Labidi‐Galy, Susana Banerjee, Ana Oaknin, Domenica Lorusso, Isabelle Ray‐Coquard

    Publicado 2021
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  17. 17
    Endometrial cancer

    Endometrial cancer por Vicky Makker, Helen Mackay, Isabelle Ray‐Coquard, Douglas A. Levine, Shannon N. Westin, Daisuke Aoki, Ana Oaknin

    Publicado 2021
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  18. 18
    Beyond the map: evidencing the spatial dimension of health inequalities

    Beyond the map: evidencing the spatial dimension of health inequalities por Yohan, Fayet, Delphine, Praud, Béatrice, Fervers, Isabelle, Ray-Coquard, Jean-Yves, Blay, Françoise, Ducimetiere, Guy, Fagherazzi, Elodie, Faure

    Publicado 2020
    Ligazón do recurso Ligazón do recurso Ligazón do recurso
    Text
    Engadir a favoritos
    Gardado en:
  19. 19
    The forefront of ovarian cancer therapy: update on PARP inhibitors

    The forefront of ovarian cancer therapy: update on PARP inhibitors por Mansoor Raza Mirza, Robert L. Coleman, Antonio González-Martı́n, Kathleen N. Moore, Nicoletta Colombo, Isabelle Ray‐Coquard, Sandro Pignata

    Publicado 2020
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  20. 20
    Ovarian clear cell carcinoma: open questions on the management and treatment algorithm

    Ovarian clear cell carcinoma: open questions on the management and treatment algorithm por Roberta Rosso, Margherita Turinetto, Fulvio Borella, Nicolás Chopin, Pierre Méeus, Andrew F. Laine, Isabelle Ray‐Coquard, Olivia Le Saux, Domenico Ferraioli

    Publicado 2025
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: